LEADER 01386nam  2200445   450 
001 9910792977003321
005 20200923020339.0
010   $a92-0-116119-0
035   $a(CKB)3710000001364603
035   $a(MiAaPQ)EBC4853318
035   $a(Au-PeEL)EBL4853318
035   $a(CaPaEBR)ebr11384239
035   $a(OCoLC)951621500
035   $a(EXLCZ)993710000001364603
100   $a20170601h20162016  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aGood practice for introducing radiopharmaceuticals for clinical use
210  1$aVienna, Austria :$cInternational Atomic Energy Agency,$d2016.
210  4$d2016
215   $a1 online resource (72 pages) $cillustrations, tables
225 1 $aIAEA TECDOC Series,$x1011-4289 ;$v1782
311   $a92-0-111215-7 
320   $aIncludes bibliographical references.
410  0$aIAEA-TECDOC ;$v1782.
606   $aRadiopharmaceuticals
606   $aRadioisotopes in medical diagnosis
615  0$aRadiopharmaceuticals.
615  0$aRadioisotopes in medical diagnosis.
676   $a616.07575
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910792977003321
996   $aGood practice for introducing radiopharmaceuticals for clinical use$93714233
997   $aUNINA